1. Home
  2. CXDO vs ELTX Comparison

CXDO vs ELTX Comparison

Compare CXDO & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CXDO

Crexendo Inc.

HOLD

Current Price

$6.19

Market Cap

223.1M

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$10.53

Market Cap

209.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXDO
ELTX
Founded
1995
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
223.1M
209.9M
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
CXDO
ELTX
Price
$6.19
$10.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$9.25
$17.00
AVG Volume (30 Days)
186.1K
117.5K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
166.67
39.29
EPS
0.16
N/A
Revenue
$68,167,000.00
$2,301,000.00
Revenue This Year
$38.52
N/A
Revenue Next Year
$19.22
N/A
P/E Ratio
$38.88
N/A
Revenue Growth
12.05
N/A
52 Week Low
$3.75
$4.60
52 Week High
$7.80
$14.93

Technical Indicators

Market Signals
Indicator
CXDO
ELTX
Relative Strength Index (RSI) 45.91 47.57
Support Level $6.08 $10.06
Resistance Level $6.73 $11.48
Average True Range (ATR) 0.27 0.85
MACD -0.03 -0.20
Stochastic Oscillator 31.38 23.05

Price Performance

Historical Comparison
CXDO
ELTX

About CXDO Crexendo Inc.

Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

Share on Social Networks: